Jeremy M Levin - Net Worth and Insider Trading
Jeremy M Levin Net Worth
The estimated net worth of Jeremy M Levin is at least $12 Million dollars as of 2024-05-25. Jeremy M Levin is the CEO of Ovid Therapeutics Inc and owns about 3,652,176 shares of Ovid Therapeutics Inc (OVID) stock worth over $11 Million. Jeremy M Levin is also the SVP Strat Transactions of Bristol-Myers Squibb Co and owns about 20,505 shares of Bristol-Myers Squibb Co (BMY) stock worth over $845,626. Details can be seen in Jeremy M Levin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeremy M Levin has not made any transactions after 2024-03-18 and currently still holds the listed stock(s).
Transaction Summary of Jeremy M Levin
Jeremy M Levin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy M Levin owns 2 companies in total, including Ovid Therapeutics Inc (OVID) , and Bristol-Myers Squibb Co (BMY) .
Click here to see the complete history of Jeremy M Levin’s form 4 insider trades.
Insider Ownership Summary of Jeremy M Levin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OVID | Ovid Therapeutics Inc | 2024-03-18 | director & 10 percent owner & CEO |
| BMY | Bristol-Myers Squibb Co | 2010-05-04 | SVP Strat Transactions |
Jeremy M Levin Latest Holdings Summary
Jeremy M Levin currently owns a total of 2 stocks. Among these stocks, Jeremy M Levin owns 3,652,176 shares of Ovid Therapeutics Inc (OVID) as of March 18, 2024, with a value of $11 Million and a weighting of 92.83%. Jeremy M Levin also owns 20,505 shares of Bristol-Myers Squibb Co (BMY) as of May 4, 2010, with a value of $845,626 and a weighting of 7.17%.
Latest Holdings of Jeremy M Levin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc | 2024-03-18 | 3,652,176 | 3.00 | 10,956,528 |
| BMY | Bristol-Myers Squibb Co | 2010-05-04 | 20,505 | 41.24 | 845,626 |
Holding Weightings of Jeremy M Levin
Jeremy M Levin Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeremy M Levin has made a total of 3 transactions in Ovid Therapeutics Inc (OVID) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Ovid Therapeutics Inc is the acquisition of 18,248 shares on March 18, 2024, which cost Jeremy M Levin around $50,365.
According to the SEC Form 4 filings, Jeremy M Levin has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 0 shares on May 4, 2010, which brought Jeremy M Levin around $0.
Insider Trading History of Jeremy M Levin
- 1
Jeremy M Levin Trading Performance
GuruFocus tracks the stock performance after each of Jeremy M Levin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeremy M Levin is 27.19%. GuruFocus also compares Jeremy M Levin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeremy M Levin within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeremy M Levin's insider trading performs compared to the benchmark.
Performance of Jeremy M Levin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.61 | | | | | |
| Relative Return to S&P 500(%) | 10.12 | | | | | |
Jeremy M Levin Ownership Network
Jeremy M Levin Owned Company Details
What does Ovid Therapeutics Inc do?
Who are the key executives at Ovid Therapeutics Inc?
Jeremy M Levin is the director & 10 percent owner & CEO of Ovid Therapeutics Inc. Other key executives at Ovid Therapeutics Inc include Chief Commercial Officer Jason Tardio , 10 percent owner Takeda Pharmaceuticals U.s.a., Inc. , and CMO and PMO Amit Rakhit .
Ovid Therapeutics Inc (OVID) Insider Trades Summary
Over the past 18 months, Jeremy M Levin made 1 insider transaction in Ovid Therapeutics Inc (OVID) with a net purchase of 18,248.
In summary, during the past 3 months, insiders sold 0 shares of Ovid Therapeutics Inc (OVID) in total and bought 18,248 shares, with a net purchase of 18,248 shares. During the past 18 months, 0 shares of Ovid Therapeutics Inc (OVID) were sold and 18,248 shares were bought by its insiders, resulting in a net purchase of 18,248 shares.
Ovid Therapeutics Inc (OVID)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ovid Therapeutics Inc Insider Transactions
Jeremy M Levin Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy M Levin. Currently GuruFocus does not have mailing address information for Jeremy M Levin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
